Beiersdorf to join DAX, Deutsche Boerse says
4 December 2008 00:00 in Medical Company Financials
Beiersdorf is to join Germany's top 30 index, the DAX, according to Frankfurt stock market Deutsche Boerse.
The addition will be in replacement of Hypo Real Estate and will take effect from December 22nd, the company said.
Last month, a French consumer test has found Beiersdorf's Nivea Visage DNAge is more effective than anti-ageing products six times its price.
The trial by 60 Millions de Consommateurs magazine found the item - which was also the cheapest - to be the second most effective product out of the 12 examined.
All of the products were tested under laboratory conditions, with each used by 22 female volunteers - who were aged between 30 and 70 years old - over a period of 28 days.
Earlier in November, Beiersdorf announced its third-quarter profits had fallen 17 per cent.
Attributed to a difficult current economic climate, the company's net profit from July to September this year fell to 108 million euros (93.5 million pounds), down from 130 million euros a year before.
However, the company added it will stay with its forecast for the full year.
Beiersdorf employs over 22,000 people worldwide, of which 870 are in research and development (R&D).
The company spent 127 million euros on R&D in 2007.
Other news stories from 04/12/2008
Read more in the Zenopa News Archive
How this news is generated
Story collated for Zenopa by the Adfero News Agency